Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease

A Statement of the American Thoracic Society and European Respiratory Society

Source: Guideline 1999
Number: 1999

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A Statement of the American Thoracic Society and European Respiratory Society. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. Guideline 1999

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 2014
Year: 2014

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020

Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020

Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019

A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009


Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017

The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017

Nutritional Disorders of Patients with Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019

From the Cradle to the Grave - The Early-Life Origins of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020

Impulse Oscillometry in Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


Chronic Obstructive Pulmonary Disease: A Forgotten Killer
Source: Eur Respir J 2009; 33: 456
Year: 2009


No-Sedation in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients;A Rondomized Controlled Trial
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017